21st Annual Pharmaceutical and Medical Device Ethics and Compliance Congress

Gejaa Gobena and Thomas Beimers spoke at the virtual 21st Annual Pharmaceutical and Medical Device Ethics and Compliance Congress.

HHS anti-kickback and Stark proposed rules: Impact on value-based care and longstanding regulatory hurdles

CMS and OIG proposed wide-ranging protections for value-based arrangements and provided guidance on a number of regulatory challenges under the AKS and Stark Law. On November 14, join us...

Proposed AKS rewrite on drug rebates: The impact and challenges ahead

The Trump Administration recently proposed what is arguably the most sweeping change to the regulatory safe harbors for the federal health care anti-kickback statute in decades. The...

Loading data